Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)
Observational
Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Longitudinal, Time Perspective: Prospective
Pär I Johansson, MD
Study Chair
Rigshospitalet, Denmark
Denmark: Ethics Committee
TEG-Onkologi
NCT00400504
November 2006
Name | Location |
---|